Ventricular Arrhythmia
📧 Sign up to get email alerts when something new happens for Ventricular Arrhythmia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-09-09Clinical Trial Update: Radiofrequency Ablation of Symptomatic Frequent Ventricular Premature Complexes in Pediatric Population [Phase 2, Phase 3]
This document provides an update on a pediatric clinical trial evaluating radiofrequency ablation for symptomatic frequent ventricular prema…
-
CLINICAL_TRIALS trial_result · 2016-07-19Clinical Trial Update: Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone
A completed clinical trial update evaluated the risk of ventricular arrhythmia and sudden cardiac death among domperidone users.
-
CLINICAL_TRIALS trial_result · 2016-05-30Clinical Trial Update: Dose Ranging Study of Celivarone With Amiodarone as Calibrator for the Prevention of Implantable Cardioverter Defibrillator (ICD) Interventions or Death [Phase 2]
A completed Phase 2 dose-ranging study evaluating Celivarone with amiodarone as a calibrator to prevent ICD interventions or death from vent…
-
CLINICAL_TRIALS trial_result · 2016-05-06Clinical Trial Update: Cardiac Arrhythmia Suppression Trial (CAST) [Phase 3]
The CAST trial, a Phase 3 cardiac arrhythmia study, has completed.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Predictors of Perioperative Cardiac Morbidity
The clinical trial results update on predictors of perioperative cardiac morbidity has completed, identifying factors associated with cardia…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-03-16Clinical Trial Update: Triggers of Ventricular Arrhythmias (TOVA) Study
Clinical trial update on the Triggers of Ventricular Arrhythmias (TOVA) study; the study examining triggers of ventricular arrhythmias in ca…
-
CLINICAL_TRIALS trial_result · 2015-12-24Clinical Trial Update: Heart Rate Variability and Sudden Cardiac Death
The completed trial investigated the relationship between heart rate variability and sudden cardiac death in patients with cardiovascular an…
-
CLINICAL_TRIALS trial_result · 2015-12-23Clinical Trial Update: Prognostic Significance of T Wave Alternans
An update on a completed trial examining the prognostic significance of T wave alternans for predicting ventricular arrhythmia risk in patie…
-
CLINICAL_TRIALS trial_result · 2015-11-17Clinical Trial Update: Anti-arrhythmic Therapy vs Catheter Ablation as First Line Treatment for AICD Shock Prevention [Phase 4]
Phase 4 trial comparing anti-arrhythmic drug therapy versus catheter ablation as the first-line strategy to prevent implantable cardioverter…
-
CLINICAL_TRIALS trial_result · 2015-10-22Clinical Trial Update: Long QT Syndrome-Population Genetics and Cardiac Studies
This completed clinical trial update reports on population genetics and cardiac studies related to Long QT Syndrome.
-
FDA approval · 2015-08-25FDA Approved: SOTALOL HYDROCHLORIDE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Sotalol hydrochloride from Aurobindo Pharma Limited. The approval confirms the generic product's…
-
FDA approval · 2015-04-29FDA Approved: MEXILETINE HYDROCHLORIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for Mexiletine Hydrochloride from ANI Pharmaceuticals, Inc., indicating regulatory approval of c…
-
CLINICAL_TRIALS trial_result · 2013-04-02Clinical Trial Update: Sleep Apnea-hypopnea Syndrome (SAHS) and Ventricular Arrhythmias [Phase 4]
A Phase 4 clinical trial evaluating Sleep apnea-hypopnea syndrome and ventricular arrhythmias has completed.
-
CLINICAL_TRIALS trial_result · 2013-03-19Clinical Trial Update: The Adjunctive Ventricular Arrhythmia Suppression Trial (AVAST) Pilot [NA]
This update reports that the AVAST Pilot trial, investigating adjunctive suppression of ventricular arrhythmias, has completed.
-
CLINICAL_TRIALS trial_result · 2012-05-08Clinical Trial Update: Double Blind Placebo Controlled Dose Ranging Study of the Efficacy and Safety of SSR149744c 100 or 300 mg for the Prevention of ventrICular ARrhythmia-triggered Icd interventiOnS [Phase 2]
Phase 2, randomized, double-blind, placebo-controlled, dose-ranging study evaluating SSR149744c at 100 mg or 300 mg for the prevention of ve…
-
CLINICAL_TRIALS trial_result · 2012-04-27Clinical Trial Update: Cardiac Arrhythmia Pilot Study (CAPS) [Phase 2]
Clinical trial CAPS, a Phase 2 cardiac arrhythmia study sponsored by NHLBI, has completed. The update lists related conditions (arrhythmia, …
-
CLINICAL_TRIALS trial_result · 2011-11-16Clinical Trial Update: Linox Smart S DX PME/Master Study [Phase 4]
Phase 4 PME/Master Study for Linox Smart S DX has completed. The trial evaluated ICD indications and was sponsored by Biotronik.
-
CLINICAL_TRIALS trial_result · 2011-01-21Clinical Trial Update: Study on Mechanical and Electrical Alternans
This clinical trial update reports on a study evaluating mechanical and electrical alternans in patients with heart failure and ischemia. Ve…
-
FDA approval · 2010-10-18FDA Approved: PROPAFENONE HYDROCHLORIDE — Original Application (Strides Pharma Science Limited)
FDA approved Propafenone hydrochloride from Strides Pharma Science Limited under an Original Application, making a generic antiarrhythmic av…
-
CLINICAL_TRIALS trial_result · 2008-02-13Clinical Trial Update: MASTER I - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients [NA]
The MASTER I trial evaluating Microvolt T Wave Alternans testing for risk stratification in post-myocardial infarction patients has complete…
-
CLINICAL_TRIALS trial_result · 2008-02-13Clinical Trial Update: MASTER II - Microvolt T Wave Alternans Testing for Risk Stratification of Post MI Patients [NA]
MASTER II evaluated microvolt T-wave alternans testing for risk stratification in post-myocardial infarction patients; the study is complete…
-
FDA approval · 2007-02-07FDA Approved: SOTALOL HYDROCHLORIDE — Original Application (Aurobindo Pharma Limited)
The FDA approved the original application for sotalol hydrochloride (generic) from Aurobindo Pharma Limited, authorizing its marketing as a …
-
CLINICAL_TRIALS trial_result · 2006-07-21Clinical Trial Update: SOFA: Study on Omega-3 Fatty Acids and Ventricular Arrhythmia [Phase 3]
Phase 3 clinical trial evaluating omega-3 fatty acids for ventricular arrhythmia has completed.